Co-Telmisartan Spirig HC 80/25 mg Tabletten Co-Telmisartan Spirig HC 80/25 mg Tabletten Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

co-telmisartan spirig hc 80/25 mg tabletten co-telmisartan spirig hc 80/25 mg tabletten

spirig healthcare ag - telmisartanum, hydrochlorothiazidum - co-telmisartan spirig hc 80/25 mg tabletten - telmisartanum 80 mg, hydrochlorothiazidum 25 mg, magnesii stearas, kalii hydroxidum corresp. kalium 6.37 mg, megluminum, povidonum k 29-32, carboxymethylamylum natricum a corresp. natrium 1.66 mg, cellulosum microcristallinum, mannitolum, pro compresso. - antihypertensivum - synthetika

Co-Dorzolamid-Mepha 2% / 0.5%.Augentropfen Co-Dorzolamid-Mepha 2% A / A 0,5%.Augentropfen Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

co-dorzolamid-mepha 2% / 0.5%.augentropfen co-dorzolamid-mepha 2% a / a 0,5%.augentropfen

mepha pharma ag - dorzolamidum, timololum - co-dorzolamid-mepha 2% a / a 0,5%.augentropfen - dorzolamidum 20 mg ut dorzolamidi hydrochloridum, timololum 5 mg ut timololi malea, mantenuto.: benzalkonii chloridum, aqua ad iniectabilia q s. annuncio solutionem pro 1 ml. - glaukom - synthetika

DANITRON Italia - italiano - Ministero della Salute

danitron

nichino europe co ltd - fenpyroximate; - sospensione concentrata - 4.97 g i valori indicati sono per 100 g di prodotto. - acaricida - acaricida - (n) pericoloso per l''ambiente (xn) nocivo

OS-169 Italia - italiano - Ministero della Salute

os-169

nihon nohyaku co. ltd - pyraflufen-etile; - concentrato emulsionabile - 2.5 g i valori indicati sono per 100 g di prodotto. - sinergizzante - sinergizzante - (n) pericoloso per l''ambiente (xn) nocivo

OVULIKE Italia - italiano - Ministero della Salute

ovulike

t.p. whelehan son & co. ltd - buserelin acetato - buserelin acetato - 0 mg/ml - buserelin

Vectormune FP ILT + AE Unione Europea - italiano - EMA (European Medicines Agency)

vectormune fp ilt + ae

ceva-phylaxia co. ltd. - live recombinant fowlpox virus expressing the membrane fusion protein and the encapsidation protein of avian infectious laryngotracheitis virus (rfp-lt) and avian encephalomyelitis virus, strain calnek 1143 (ae) - immunologicals for aves, live viral vaccines, domestic fowl - pollo - for active immunisation of chickens of 8 to 13 weeks of age in order to reduce the skin lesions due to fowlpox, to reduce the clinical signs and tracheal lesions due to avian infectious laryngotracheitis and to prevent egg production losses due to avian encephalomyelitis.

Ultifend ND IBD Unione Europea - italiano - EMA (European Medicines Agency)

ultifend nd ibd

ceva-phylaxia veterinary biologicals co. ltd - turkey herpes virus, strain rhvt/nd/ibd, expressing the fusion protein of newcastle disease virus and the vp2 protein of infectious bursal disease virus, live recombinant - immunologici per aves - embryonated chicken eggs; chicken - for the active immunisation of one-day-old chicks or 18-day-old chicken embryonated eggs to reduce mortality, clinical signs and lesions caused by newcastle disease virus (ndv) and to reduce virus shedding; to reduce mortality, clinical signs and bursa lesions caused by very virulent infectious bursal disease virus (ibdv); to reduce mortality, clinical signs and lesions caused by classical marek’s disease virus (mdv).

Vectormune FP ILT Unione Europea - italiano - EMA (European Medicines Agency)

vectormune fp ilt

ceva-phylaxia co. ltd. - recombinant fowlpox virus expressing the membrane fusion protein and the encapsidation protein of avian infectious laryngotracheitis virus, live - pollo - for active immunisation of chickens from 8 weeks of age in order to reduce the skin lesions due to fowlpox and to reduce the clinical signs and tracheal lesions due to avian infectious laryngotracheitis.

CO EFFERALGAN Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

co efferalgan

medifarm s.r.l. - codeina e paracetamolo - codeina e paracetamolo